Natco Pharma consolidated net profit rises 5.25% in the March 2025 quarter

Sales rise 14.29% to Rs 1221.00 crore

Net profit of Natco Pharma rose 5.25% to Rs 406.60 crore in the quarter ended March 2025 as against Rs 386.30 crore during the previous quarter ended March 2024. Sales rose 14.29% to Rs 1221.00 crore in the quarter ended March 2025 as against Rs 1068.30 crore during the previous quarter ended March 2024.

For the full year,net profit rose 35.81% to Rs 1885.40 crore in the year ended March 2025 as against Rs 1388.30 crore during the previous year ended March 2024. Sales rose 10.77% to Rs 4429.50 crore in the year ended March 2025 as against Rs 3998.80 crore during the previous year ended March 2024.

ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var.Sales1221.001068.30 14 4429.503998.80 11 OPM %44.8946.55 -49.5843.80 - PBDT604.20533.10 13 2526.601860.30 36 PBT505.90477.60 6 2291.401673.50 37 NP406.60386.30 5 1885.401388.30 36

Powered by Capital Market - Live News